Alexion Pharmaceuticals Articles

New Zealand declines Alexion's funding application for Solaris

21 May 2013

News briefs: Grunenthal adds to portfolio; Ajinomoto to buy Althea; Alexion's Soliris OKed in Canada

6 March 2013

Alexion tells shareholders to reject TRC's unsolicited mini-tender offer

7 February 2013

ASN meeting highlights Otsuka's tolvaptan' Alexion's Solaris and Roche's aleglitazar research

5 November 2012

EMA orphan drug committee makes 16 recommendations at May meeting

28 May 2012

Alexion to buy Enobia Pharma for potential $1 billion

30 December 2011

FDA approves Alexion’s Soliris for rare pediatric blood disorder and J&J’s Remicade for children with UC

25 September 2011

Alexion acquires Taligen Therapeutics for $111 million

2 February 2011

Australia’s fight against cancer continues with new additions to the PBS, says health minister

10 December 2010

Showing 1-9 of 9 articles

Go to beginningPrevious
  • 1
NextGo to end